NCT06615050
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203) treatment 3 not_yet_recruiting NCT00128973
Evaluation of Patients With Immune Function Abnormalities No drug interventions Not Available Not Available recruiting NCT06598332
5-Azacytidine with Steroids for Gastrointestinal GVHD (5-AZA for GVHD) treatment 0 not_yet_recruiting NCT02026934
CliniMACS® CD34+ Reagent System for Expanded Access Use No drug interventions Not Available Not Available no_longer_available NCT06626737
Dapagliflozin in Allo-HCT for AGVHD prevention 2 not_yet_recruiting NCT03064984
Blood Based Eyedrops From Different Sources in the Treatment of Severe Keratopathy No drug interventions treatment Not Available unknown_status NCT03616184
Study of Ruxolitinib in Sclerotic Chronic Graft-Versus-Host Disease After Failure of Systemic Glucocorticoids treatment 2 completed NCT02953678
A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1) treatment 2 completed NCT03894488
Clinical Evaluation of the Application of the FilmArray GI Panel in Post-HSCT Diarrhea Patients No drug interventions Not Available Not Available unknown_status NCT03112603
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3) treatment 3 completed NCT03147742
An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant Not Available Not Available approved_for_marketing NCT03139604
GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease treatment 3 completed NCT02614612
Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD treatment 1 completed NCT05722912
Expanded Access of Ruxolitinib Cream to Treat a Single Patient With cGVHD Not Available Not Available approved_for_marketing NCT06160986
Horizons Chronic Graft-Versus-Host-Disease Study No drug interventions supportive_care Not Available active_not_recruiting NCT06649201
Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation No drug interventions Not Available Not Available not_yet_recruiting NCT05531786
Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) treatment 1 / 2 recruiting NCT05621759
Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD prevention 2 recruiting NCT04014790
RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Cell Transplantation prevention 2 completed NCT02322190
Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD treatment 2 terminated NCT03836690
Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation No drug interventions treatment 1 unknown_status NCT00117702
Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus treatment 2 / 3 terminated NCT00810602
Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant treatment 1 / 2 completed NCT02867384
Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell Transplantation treatment 2 active_not_recruiting NCT02876679
Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT prevention 2 completed NCT01940796
Phase I Trial of Brentuximab Vedotin for Refractory Chronic Graft-vs.-Host Disease (GVHD) treatment 1 terminated NCT04448587
Sitagliptin for the Treatment of Grade 3-4 and Refractory Acute Graft-versus-host Disease treatment 2 unknown_status NCT05780554
Post-transplantation Cyclophosphamide in Haploidentical Stem Cell Allografts Dose Reduction: 50 mg/kg vs 25 mg/kg prevention Not Available enrolling_by_invitation NCT03369353
Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy and Transplantation (The PREDICT Trial) No drug interventions Not Available Not Available enrolling_by_invitation NCT01665677
Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation prevention 2 completed NCT00350545
A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease treatment Not Available completed NCT00314483
Evaluation of the Role of Mesenchymal Stem Cells in the Treatment of Graft Versus Host Disease No drug interventions treatment 1 / 2 unknown_status NCT04473911
Haplo Peripheral Blood Sct In GVHD Prevention treatment 1 active_not_recruiting NCT01287078
Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans Syndrome treatment 2 completed NCT05333978
Optoacoustic Detection of Inflammation Using MSOT Device No drug interventions diagnostic Not Available recruiting NCT04558788
Cellular Stress Reactions During Graft-versus-host Disease No drug interventions Not Available Not Available completed NCT04622956
GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant Cyclophosphamide prevention 1 / 2 recruiting NCT04337515
A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant No drug interventions treatment Not Available recruiting NCT02172937
Decidual Stromal Cells as Treatment for Acute Graft Versus Host Disease, a Phase 1-2 Study treatment 1 / 2 unknown_status NCT01393132
Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye treatment 2 completed NCT01764100
Mesenchymal Stromal Cells (MSCs) for the Treatment of Graft Versus Host Disease (GVHD) No drug interventions treatment 1 unknown_status NCT02923375
A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease treatment 1 completed NCT00179075
Repository: Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant No drug interventions Not Available Not Available completed NCT05968170
TCRαβ/CD19 Depletion of Stem Cell Grafts for Transplant No drug interventions treatment Not Available not_yet_recruiting NCT00574470
Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD treatment 4 completed NCT00179049
Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant No drug interventions Not Available Not Available completed NCT01700036
A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host Disease treatment 2 completed NCT04922736
Patient Reported Outcomes With UVA-1 Therapy for Treatment of Sclerosing Skin Diseases No drug interventions treatment Not Available enrolling_by_invitation NCT01596218
Brentuximab Vedotin for Steroid Refractory GvHD treatment 1 completed NCT00759018
Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD Not Available Not Available no_longer_available NCT02385019
A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease No drug interventions treatment 1 / 2 unknown_status NCT00186641
High Dose Chemotherapy and Autologous Transplant for Breast Cancer No drug interventions treatment 2 unknown_status NCT05111834
IRENE-G Study: Impact of Resistance Exercise and Nutritional Endorsement on GvHD Symptoms No drug interventions supportive_care Not Available recruiting NCT02478424
Extended Use of Cannabidiol for the Prevention of Graft-versus-host-disease prevention 2 unknown_status NCT03731624
Diadenosine Polyphosphates and Mucin Associated With Ocular Surface Disorders No drug interventions Not Available Not Available unknown_status NCT00298324
Myfortic - Treatment for Extensive cGvHD treatment 3 terminated NCT03842696
Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation prevention 1 / 2 recruiting NCT00632658
Development and Validation of a Symptom Scale for Children With Chronic Graft-versus-Host Disease No drug interventions Not Available Not Available completed NCT00128739
Treatment of Gastro-Intestinal and/or Hepatic Graft Versus Host Disease With Budesonide in Patients Following Peripheral Blood Stem Cell Transplantation treatment 3 completed NCT00106925
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants No drug interventions Not Available Not Available recruiting NCT00144430
Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in Children treatment 2 completed NCT01175148
Atorvastatin for the Prophylaxis of Acute GVHD in Patients Undergoing Matched Sibling Allogeneic Transplantation prevention 2 completed NCT00001748
HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies No drug interventions treatment 1 completed NCT03136757
Analysis of Transcriptomic Profile of Graft-versus-host Disease (GHVD) After Allogeneic Grafting of Hematopoietic Stem Cells No drug interventions Not Available Not Available unknown_status NCT01512498
Vulvovaginal Graft Versus Host Disease (VV-GVHD) in Women Who Underwent Transplantation Before and After Menarche No drug interventions Not Available Not Available completed NCT00189761
A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients treatment 2 completed NCT00032279
Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host Disease treatment 2 unknown_status NCT02105766
Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure treatment 2 recruiting NCT01688466
Pomalidomide for Chronic Graft-versus-Host Disease treatment 2 completed NCT05132166
A Randomized Phase II Study to Compare the Potential Long-Lasting Positive Effect of Decidual Stromal Cells to the Best Available Treatment in Graft Versus Host Disease No drug interventions treatment 2 active_not_recruiting NCT04044365
Pediatric cGVHD Symptom Scale No drug interventions Not Available Not Available recruiting NCT00224874
Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302) treatment 2 completed NCT03591874
Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease treatment 3 terminated NCT03774082
Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant treatment 2 active_not_recruiting NCT01851382
Collection of Saliva and/ or Peripheral Blood From Healthy Volunteers for Research No drug interventions Not Available Not Available completed NCT02506231
The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation Outcome prevention 2 / 3 unknown_status NCT00001873
The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers No drug interventions treatment 2 completed NCT00000591
T-Cell Depletion in Unrelated Donor Marrow Transplantation No drug interventions treatment 3 completed NCT00025662
Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS No drug interventions treatment 2 completed NCT00388362
Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease treatment 2 completed NCT05236062
Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial No drug interventions supportive_care Not Available recruiting NCT00048789
Extracorporeal Photopheresis to Treat Chronic Graft-Versus-Host Disease No drug interventions treatment 2 completed NCT00563589
Mycophenolate Mofetil for the Prophylaxis of Graft-versus-host Disease in High Risk Allogeneic Stem Cell Transplantation prevention Not Available unknown_status NCT00001144
Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia No drug interventions treatment 2 completed NCT05333367
MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy No drug interventions basic_science Not Available unknown_status NCT03575767
Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCT No drug interventions Not Available Not Available completed NCT06143501
Alterations in Intestinal Microbiota, Metabolites, and Immune Cells in Allo-HSCT No drug interventions Not Available Not Available recruiting NCT01788501
Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease prevention 2 / 3 completed NCT00001872
Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease No drug interventions Not Available Not Available completed NCT01790568
Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell Transplant prevention 2 completed NCT04070781
Itacitinib and Tocilizumab for Steroid Refractory Acute Graft Versus Host Disease treatment 1 terminated NCT00195481
Study Evaluating Sirolimus in Kidney Transplant Recipients in India treatment 4 completed NCT02337595
Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation No drug interventions prevention 1 / 2 completed NCT00409695
Thymoglobulin (ATG) Dose Finding Study treatment 1 / 2 terminated NCT05238155
Evaluation of the Impact of Reduced Immunosuppression No drug interventions Not Available Not Available enrolling_by_invitation NCT00670423
A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation treatment 1 completed NCT01234623
Cord Blood Serum in the Treatment of Ocular Surface Diseases No drug interventions Not Available Not Available completed NCT00001623
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia No drug interventions treatment Not Available completed NCT04227938
ALPN-101 in Steroid-resistant or Steroid-refractory Acute GVHD treatment 1 terminated NCT01972438
A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) Patients No drug interventions treatment 2 terminated NCT04131738
Baricitinib for the Prophylaxis of Graft-Versus-Host Disease After Peripheral Blood Hematopoietic Cell Transplantation treatment 1 completed NCT00136903
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD) treatment 2 completed NCT02891603
A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression prevention 1 / 2 completed NCT06080490
Tacrolimus Blood Concentration and Transplant-related Outcomes in Pediatric HSCT Recipients Not Available Not Available recruiting NCT02411084
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD treatment 3 terminated NCT01282879
Evaluation of Antifungal Prophylaxis on Graft-versus-host Disease (GVHD) Patients prevention 4 terminated NCT03474679
A Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Steroid Dependent/Refractory Chronic Graft Versus Host Disease (cGVHD) treatment 3 completed NCT05018754
Treatment of Oral Mucositis Using Platelet Rich Fibrin TREATMENT OF ORAL MUCOSITIS USING PRF No drug interventions Not Available Not Available completed NCT00130754
Thymoglobuline in Non-myeloablative Allogeneic Stem-cell Transplantation prevention 3 completed NCT05170347
oGVHD After Bone Marrow Transplantation: a Territory-wide Cohort No drug interventions Not Available Not Available recruiting NCT00167947
Study Evaluating Sirolimus in Kidney Transplant Recipients. treatment 3 completed NCT02027805
Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD treatment 1 / 2 completed NCT03093805
Topical Vitamin D in Acute Graft Versus Host Disease of the Skin No drug interventions treatment Not Available completed NCT04752397
The Influence of Extracorporeal Photopheresis on Skin Sclerosis No drug interventions Not Available Not Available completed NCT00102583
Cyclosporine Implant for Ocular Graft-Versus-Host Disease treatment 1 completed NCT00001561
Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation treatment 3 completed NCT02396628
Ruxolitinib In GvHD No drug interventions treatment 2 terminated NCT06568328
Chimeric Natural Killer Receptor-Universal T Cells for Refractory GVHD No drug interventions treatment 1 recruiting NCT00146978
Intra-Arterial Catheter Directed Therapy for Severe Graft vs. Host Disease (GVHD) No drug interventions Not Available 1 / 2 completed NCT05167188
Evaluation of GvHD Damage on Medullary Mesenchymal Stem Cells No drug interventions Not Available Not Available recruiting NCT00517907
Safety Study of Preimplantation Factor (PIF-1) to Treat Acute Steroid-Resistant Graft-Versus-Host Disease (GVHD) treatment 1 unknown_status NCT01950507
Evaluation of Budesonide and How It Interacts With Antifungal Drugs in People With Gastrointestinal Graft-Versus-Host Disease treatment 1 terminated NCT01206309
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation No drug interventions Not Available Not Available completed NCT01042509
Combination of Alemtuzumab and Rituximab at Low-doses in Refractory Chronic Graft-Versus-Host Disease treatment Not Available completed NCT03546556
18-FLT PET/MR Imaging to Predict Graft Failure and GVHD in Bone Marrow Transplant Patients diagnostic 0 terminated NCT00001637
Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults No drug interventions treatment 2 completed NCT03229200
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib. treatment 4 enrolling_by_invitation NCT01713400
Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease treatment 2 completed NCT00391170
Dexamethasone to Prevent Oral Chronic Graft-versus-Host Disease prevention 2 completed NCT02737306
A Study of Acute Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Stem-Cell Transplantation treatment 2 terminated NCT04235036
Ibrutinib and Rituxan for Chronic GVHD treatment 2 terminated NCT02409134
Cognitive Function and Patient-Reported Quality of Life Outcomes Investigation in Patients Taking Vorinostat No drug interventions Not Available Not Available completed NCT01994824
Preemptive Therapy of GVHD prevention 2 terminated NCT01318330
Safety Study of Homeo-GH (Bone Marrow Derived Clonal Mesenchymal Stem Cell) to Treat Acute/Chronic Graft Versus Host Disease (GVHD) No drug interventions Not Available 1 completed NCT00548717
Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation prevention 2 terminated NCT00189748
A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension- treatment 2 completed NCT00031148
Keratinocyte Growth Factor to Prevent Acute GVHD No drug interventions prevention 1 / 2 completed NCT03315741
The Safety and Tolerability of Pirfenidone for BOS After HCT treatment 1 completed NCT02172924
A Phase 2 Study Using Placenta Derived Decidual Stromal Cells for Graft Versus Host Disease No drug interventions treatment 1 / 2 unknown_status NCT03963024
Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT treatment 1 terminated NCT02829216
Graft-versus-host Disease Associated Myelosuppression No drug interventions Not Available Not Available unknown_status NCT00136396
Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease treatment 1 / 2 completed NCT00233896
Randomized Study of Oral Beclomethasone Dipropionate With Ten Days of Prednisone for Treatment of Gastrointestinal GVHD treatment 3 completed NCT03207958
Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation treatment 1 completed NCT00228839
GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease treatment 1 completed NCT05617625
CD34+ Enriched Transplants to Treat Myelodysplastic Syndrome treatment 2 suspended NCT06450925
Vitamin A Supplementation in Allogeneic Stem Cell Transplantation. prevention 2 not_yet_recruiting NCT02683525
Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation treatment 2 completed NCT01327625
Efficacy Study of Azithromycin-based Therapy for Bronchiolitis Obliterans treatment Not Available terminated NCT00001830
Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants No drug interventions treatment 1 completed NCT00023530
Blood and Marrow Transplant Clinical Research Network prevention Not Available completed NCT02770430
Mesenchymal Stem Cells as First Treatment Line for Resistant Acute Graft Versus Host Disease treatment 2 unknown_status NCT00770757
CC-4047 (Pomalidomide) for Graft vs. Host Disease treatment 2 completed NCT02319226
Toward Immune Biomarkers for Tolerance and GvHD in Humans No drug interventions Not Available Not Available unknown_status NCT05153226
GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG prevention 3 recruiting NCT01221766
Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease No drug interventions Not Available Not Available completed NCT00248365
Theralux Extracorporeal Photochemotherapy (ECP) in Patients With Extensive Chronic Graft Versus Host Disease (GvHD) No drug interventions treatment 1 / 2 completed NCT05718674
Photopheresis in GvHD After Hematopoietic Transplantation: Characteristics of the Procedure and of the Cell Product No drug interventions Not Available Not Available enrolling_by_invitation NCT00044720
Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients Not Available 4 completed NCT04687982
Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002). No drug interventions prevention Not Available completed NCT00037531
Study Evaluating Sirolimus (Rapamune™) in Solid Organ Transplant Recipients Not Available 3 completed NCT01743131
Abatacept as GVHD Prophylaxis Phase 2 prevention 2 completed NCT00195273
Study Evaluating Sirolimus in Kidney Transplant Recipients treatment 3 completed NCT02945176
Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation No drug interventions diagnostic Not Available completed NCT01902576
Chronic GVHD Response Measures Validation No drug interventions Not Available Not Available active_not_recruiting NCT05152160
Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease No drug interventions treatment 1 / 2 unknown_status NCT00023491
Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells No drug interventions Not Available Not Available completed NCT00578591
Rituximab for GVHD treatment 2 withdrawn NCT00035880
Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease treatment 2 / 3 completed NCT02997280
Ruxolitinib for Steroid-refractory GVHD treatment 2 completed NCT00195429
A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients treatment 4 completed NCT02525029
Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD supportive_care 1 / 2 completed NCT06133192
Steroids Versus ECP and Steroids as First-line Treatment of Grade II Acute GVHD treatment 2 not_yet_recruiting NCT00207792
Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation treatment 3 unknown_status NCT00032292
Research Study of Visilizumab for Treatment of Acute Graft Versus Host Disease treatment 1 / 2 completed NCT04380740
Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis treatment 2 recruiting NCT00186667
Sirolimus as Primary Therapy for the Treatment of Chronic Graft Versus Host Disease No drug interventions treatment 2 completed NCT04678401
IS-free Treg HaploHCT treatment 1 recruiting NCT03434704
Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole treatment 2 completed NCT02064972
CEC Count Changes to Support GvHD Diagnosis. No drug interventions Not Available Not Available completed NCT00195468
Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus treatment 4 completed NCT04728646
Evaluation of Dextenza in Patients With Ocular GVHD and Effects on Ocular Surface Disease Outcomes treatment 4 withdrawn NCT01699412
Clinical Trial With Clobetasol and Dexamethasone for Topical Treatment of Oral Lesions of Chronic Graft-versus-host Disease treatment 3 completed NCT04738981
Efficacy and Safety of UC-MSCs for the Treatment of Steroid-resistant aGVHD Following Allo-HSCT treatment 3 completed NCT00760981
A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host Disease treatment 1 completed NCT02841995
A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease treatment 2 completed NCT04479995
Multidisciplinary Intervention In Chronic GVHD No drug interventions supportive_care Not Available active_not_recruiting NCT03340155
Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases No drug interventions other Not Available unknown_status NCT03172455
Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT) Not Available Not Available no_longer_available NCT06008808
Ruxolitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation prevention 1 recruiting NCT00563108
Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation treatment Not Available unknown_status NCT02398708
Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT No drug interventions Not Available Not Available completed NCT00655343
Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT) prevention 3 completed NCT00088543
Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant Not Available Not Available completed NCT05866302
Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients No drug interventions Not Available Not Available recruiting NCT03456817
HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis treatment 2 recruiting NCT03602599
Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls No drug interventions Not Available Not Available recruiting NCT03983850
Optimizing PTCy Dose and Timing treatment 1 / 2 recruiting NCT04144036
Neihulizumab for Standard-Risk Acute Graft Versus Host Disease (GVHD) treatment 1 completed NCT05263999
A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR) treatment 3 recruiting NCT05622318
De-escalated Cyclophosphamide (PTCy) and Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis treatment 2 recruiting NCT06392711
Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia treatment 1 recruiting NCT05675930
A Study of Photobiomodulation (PBM) Therapy in People with Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant No drug interventions treatment 2 recruiting NCT00489203
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer supportive_care 2 completed NCT00002790
Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant supportive_care 1 / 2 withdrawn NCT00716690
Multi Donor Mismatched Stem Cell Transplantation (MDT) No drug interventions treatment 1 / 2 unknown_status NCT00749164
Allogeneic Mesenchymal Stem Cell for Graft-Versus-Host Disease Treatment No drug interventions treatment 1 / 2 unknown_status NCT01233921
Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer supportive_care Not Available completed NCT04688021
A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT. prevention 2 recruiting NCT00492921
High-Dose Cyclophosphamide for Steroid Refractory GVHD supportive_care 2 completed NCT03204721
Prevention of GVHD in Patients Treated With Allogeneic SCT: Possible Role of Extracorporeal Photophoresis No drug interventions prevention Not Available completed NCT02483702
Irradiated Blood Versus Non Irradiated Blood Transfusions in Craniosynostosis Repair No drug interventions prevention Not Available completed NCT00255684
Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer treatment Not Available terminated NCT03846479
Itacitinib for Low Risk GVHD treatment 2 completed NCT00093587
Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia supportive_care Not Available unknown_status NCT00824954
Extracorporeal Photopheresis in Children and Young Adults With Refractory Acute Graft Versus Host Disease No drug interventions treatment 2 unknown_status NCT00006054
Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies treatment Not Available terminated NCT03361254
Cryopreservation of White Blood Cells Before Their UVA Irradiation for Graft Versus Host Disease Treatment No drug interventions treatment Not Available unknown_status NCT00006451
Bone Marrow Transplantation in Treating Patients With Leukemia treatment 3 withdrawn NCT02824653
Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD No drug interventions treatment 1 / 2 completed NCT00144677
Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation prevention 2 completed NCT00043147
Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease supportive_care 3 completed NCT06238245
Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade prevention 2 not_yet_recruiting NCT00923845
Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer treatment 2 completed NCT00366145
Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD) treatment 3 completed NCT00003398
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer treatment 4 completed NCT02248597
Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases treatment 2 completed NCT01309997
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease treatment 2 completed NCT00450983
Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases treatment 2 terminated NCT00079183
Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment supportive_care 2 completed NCT00003661
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00096161
Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant treatment 2 completed NCT00109993
Campath-1H + FK506 and Methylprednisolone for GVHD supportive_care 2 completed NCT00943293
Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies treatment 1 terminated NCT03419078
Nutrition and Outcomes of Hematopoietic Cell Transplantation (HCT) No drug interventions Not Available Not Available completed NCT00577278
A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan treatment 2 completed NCT02203578
Romidepsin in Treating Patients With Steroid-Refractory Graft-versus-Host Disease supportive_care Not Available terminated NCT00005988
Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy treatment 1 completed NCT01273207
Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans treatment 2 completed NCT00382109
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission treatment 3 completed NCT01379209
Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT) treatment 1 / 2 completed NCT00609609
Photopheresis for the Treatment of Acute Graft Versus Host Disease treatment 2 completed NCT02109809
Low-Dose Total Lymphoid Irradiation in Treating Patients With Refractory Chronic Graft-versus-Host Disease After Donor Stem Cell Transplant No drug interventions supportive_care Not Available terminated NCT00002456
Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation supportive_care 3 completed NCT00006056
Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders treatment Not Available unknown_status NCT00003056
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation supportive_care 3 terminated NCT00360685
Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX treatment Not Available completed NCT00373815
Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease treatment 1 terminated NCT00544115
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders treatment 2 active_not_recruiting NCT00089037
Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation supportive_care 1 / 2 completed NCT00004232
Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer supportive_care 1 completed NCT05694832
Expressive Writing in GVHD No drug interventions treatment 0 enrolling_by_invitation NCT00005852
Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant treatment 2 terminated NCT04231500
The Skin Microbiome in Graft Versus Host Disease No drug interventions Not Available Not Available recruiting NCT00054600
Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host Disease prevention 2 completed NCT02867800
Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease treatment 1 completed NCT00346359
Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer treatment 2 completed NCT00007059
Study of the Pharmacokinetics of Mycophenolate Mofetil in Patients Who Have Undergone Orthotopic Liver Transplantation treatment Not Available completed NCT00056875
Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants No drug interventions prevention 1 / 2 completed NCT01596075
Safety and Efficacy of Cannabidiol for Grade I/II Acute Graft Versus Host Disease (GVHD) After Allogeneic Stem Cell Transplantation treatment 1 / 2 unknown_status NCT02379442
Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids No drug interventions treatment 1 / 2 terminated NCT04342442
Identification of Novel Targetable Kinases in SR-a GvHD No drug interventions Not Available Not Available completed NCT00900406
Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant No drug interventions Not Available Not Available completed NCT04014413
Safety and Efficacy of Fecal Microbiota Transplantation No drug interventions treatment Not Available recruiting NCT00361413
Alefacept for Prevention of Graft Versus Host Disease (GVHD) prevention 3 terminated NCT02086513
Phase I Trial of LDE225 for Steroid-refractory Chronic GVHD After Allogeneic HSCT treatment 1 terminated NCT00813618
Study of MEDI 507 in the Treatment of Pediatric Patients treatment 1 completed NCT00376519
Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases treatment 1 terminated NCT00005641
Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation treatment 2 terminated NCT00608517
Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil treatment Not Available terminated NCT00639717
Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant prevention 2 completed NCT03818334
Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies prevention 2 / 3 recruiting NCT04503616
Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention prevention 1 / 2 active_not_recruiting NCT00489216
Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids supportive_care Not Available terminated NCT01522716
Mesenchymal Stromal Cells as Treatment of Chronic Graft-versus-host Disease treatment 1 terminated NCT02976558
The Influence of TaKeTiNa Music Therapy, Traditional Chinese Acupuncture and Clown Theatrical Performance on Quality of Life and the Therapeutic Process of Patients Undergoing Allogenic Stem Cell Transplantation No drug interventions treatment Not Available terminated NCT00438958
Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases treatment 3 completed NCT00074035
Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease supportive_care 2 completed NCT02174263
Tocilizumab for Chronic Graft-versus-Host Disease Treatment supportive_care 2 withdrawn NCT00589563
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer supportive_care 2 completed NCT02849886
T Lymphocytes (LT) Expressing iCASP9 and ΔCD19 in Allogeneic Haematopoietic Transplantation. prevention 1 / 2 unknown_status NCT00201786
Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host Disease treatment 2 completed NCT02151539
Prospective Outcomes of Second-Line Therapy in Acute Graft-Versus-Host Study Including ECP (POSTAGE) No drug interventions Not Available Not Available terminated NCT01222039
Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease. No drug interventions treatment 1 / 2 completed NCT00141739
Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT) treatment 2 completed NCT02663622
Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002) treatment 2 completed NCT02956122
A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD treatment 2 / 3 terminated NCT06304025
Sequential Administration of WJ-MSCs for the Treatment of GvHD Refractory to Second Line Treatment treatment 1 / 2 not_yet_recruiting NCT02144025
Prevention of Ocular Graft-Versus-Host Disease With Topical Cyclosporine in Recipients of Allogeneic HSCT prevention 2 completed NCT00555048
Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer treatment 1 / 2 terminated NCT05186857
Metabolome and Microbiome Impact on Acute GVHD in Recipients of Hematopoietic Transplant No drug interventions Not Available Not Available active_not_recruiting NCT00986557
T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant supportive_care 2 unknown_status NCT03147157
The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen After Liver Transplantation No drug interventions treatment Not Available not_yet_recruiting NCT01810926
T&B Depletion Non Malignant prevention 2 unknown_status NCT01111526
Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease (GVHD) treatment 1 / 2 completed NCT00055666
Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal Tract supportive_care Not Available completed NCT01549665
Umbilical Cord Blood-derived Mesenchymal Stem Cells for the Treatment of Steroid-refractory Acute or Chronic Graft-versus-host-disease No drug interventions treatment 1 / 2 unknown_status NCT00282282
Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation treatment 2 completed NCT02176031
Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD treatment 2 completed NCT06423131
Prospective Clinical Trial for Children With TCRαβ Depleted vs Traditional Haplo Identicle HSCT No drug interventions treatment Not Available recruiting NCT02942173
CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT No drug interventions prevention 2 / 3 completed NCT03605927
CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease prevention 1 completed NCT03102060
Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplant No drug interventions prevention Not Available terminated NCT03395860
Low Dose ATG Plus Low Dose PTCy as GVHD Prophylaxis in Haplo-HSCT No drug interventions treatment 2 unknown_status NCT00725062
Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant No drug interventions treatment 1 terminated NCT04792580
The Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Subjects With Dry Eye Disease in Ocular Graft-versus-Host Disease treatment 0 completed NCT01616680
Brentuximab Vedotin in Treating Patients With Steroid-Resistant Acute Graft-Versus-Host Disease supportive_care 2 withdrawn NCT00720629
Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation prevention 2 terminated NCT02359929
BMT Autologous MSCs for GvHD treatment 1 completed NCT01754389
Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant treatment 2 completed NCT00914940
Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD treatment 2 terminated NCT03395340
Topical Ruxolitinib for Cutaneous Chronic Graft Versus Host Disease (cGVHD) treatment 2 terminated NCT02812940
Single-centre Study of Everolimus as GvHD Prophylaxis After Post-Transplantation Cyclophosphamide After Allogeneic SCT prevention 2 completed NCT00912067
Ocular Graft Versus Host Disease After Hematopoietic Stem Cell Transplantation in Adults No drug interventions Not Available Not Available unknown_status NCT01991301
Carfilzomib for the Prevention of Graft Versus Host Disease No drug interventions treatment 1 unknown_status NCT04838704
Ruxolitinib With Calcineurin and Methotrexate vs. Calcineurin Plus Methotrexate and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis for HLA-haploidentical Hematopoietic Stem Cell Transplantation prevention 4 recruiting NCT00450268
Dendritic Cells in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation No drug interventions Not Available Not Available unknown_status NCT00014469
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer treatment 2 completed NCT00623012
Rapamycin for Prevention of Chronic Graft-Versus-Host Disease treatment 1 / 2 terminated NCT04669210
PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT prevention 2 active_not_recruiting NCT00255710
Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer supportive_care 1 completed NCT02891395
Efficacy and Safety of Nilotinib in Patients With a Chronic Disease of the Graft Against the Host treatment 2 completed NCT01369914
The Natural History of Graft-Versus-Host Disease in the Eyes No drug interventions Not Available Not Available completed NCT00600314
Measurements of Resting Energy Expenditure in Patients With or at Risk of Developing Graft Versus Host Disease No drug interventions Not Available Not Available unknown_status NCT01460914
Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis Treatment No drug interventions Not Available Not Available active_not_recruiting NCT00146614
Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation treatment 2 completed NCT00003414
Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease treatment 3 completed NCT00004255
Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation treatment 2 / 3 completed NCT00454155
Study of Opebacan in Patients Undergoing Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) prevention 1 / 2 terminated NCT00006055
Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases treatment Not Available unknown_status NCT00081055
OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies supportive_care 2 withdrawn NCT00179855
Extracorporeal Photopheresis for Acute Graft Versus Host Disease No drug interventions treatment 2 / 3 unknown_status NCT00075023
Effectiveness of Topical Thalidomide to Treat Chronic Graft-Versus-Host-Disease Related Stomatitis treatment 2 terminated NCT05158608
Comparison of PT-Cy at a Dose of 25 mg/kg/Day and PT-Cy at a Dose of 50 mg/kg/Day in GVHD Prophylaxis prevention 3 not_yet_recruiting NCT00993343
Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation prevention 3 completed NCT03438643
Dynamic of Immunocompetent Populations in Patients Treated With Extracorporeal Photopheresis in Chronic Graft Versus Host Disease No drug interventions Not Available Not Available recruiting NCT02145403
Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies treatment 1 / 2 completed NCT06321003
SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography No drug interventions Not Available Not Available recruiting NCT00524784
Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD No drug interventions prevention 1 / 2 unknown_status NCT02660684
Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule/Injection) and Methotrexate (MTX) Combination Therapy for Prevention of Graft Versus Host Disease (GVHD) in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation From a Sibling Donor treatment 4 completed NCT04660487
Relationship Between "FODMAPs" and "GVHD" No drug interventions Not Available Not Available recruiting NCT05621733
A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea No drug interventions Not Available Not Available recruiting NCT00002833
Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia treatment 2 completed NCT00506233
Feasibility Study of Collecting Multicenter Chronic GVHD Data No drug interventions Not Available Not Available completed NCT00616954
A Study to Evaluate the Effect of ATG-F on Engraftment, Graft Versus Host Disease (GVHD) and Graft Versus Leukemia (GVL) Effect in Haplo-identical SCT No drug interventions treatment 3 terminated NCT00017654
Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia treatment Not Available unknown_status NCT02707354
Early Detection of Mucosal Abnormalities in Graft-versus-host Disease No drug interventions diagnostic Not Available completed NCT00611351
Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer treatment 2 completed NCT00948753
Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation treatment 1 / 2 completed NCT01487577
Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD Prevention treatment 2 completed NCT01174277
Pilot Study: Patients With Chronic Active Graft Versus Host Disease That Have Failed or Not Tolerated Standard Therapy. No drug interventions Not Available Not Available completed NCT00006747
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma treatment 2 completed NCT03414645
Topical Fibrinogen-Depleted Human Platelet Lysate in Patients With Dry Eye Secondary to Graft vs. Host Disease treatment 1 / 2 completed NCT01044745
Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer treatment 2 terminated NCT01066598
A Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease (cGVHD) treatment 2 terminated NCT00827398
Treatment of Steroid Resistant GVHD by Infusion MSC No drug interventions treatment 1 / 2 completed NCT03148197
Changes in the Gut Microbiota of Patients Undergoing Allogeneic Stem Cell Transplantation (COLLECT) No drug interventions Not Available Not Available unknown_status NCT03192397
Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant treatment 1 / 2 active_not_recruiting NCT00562497
Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD) treatment 3 completed NCT03339297
An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD) treatment 2 completed NCT02178683
Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression treatment 3 unknown_status NCT00010283
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon supportive_care 1 / 2 completed NCT00408928
Study on the Safety and Effectiveness of VELCADE® in the Treatment of Graft-Versus-Host Disease treatment 2 completed NCT00290628
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer treatment Not Available terminated NCT00806728
Study of MEDI-507 in With Steroid-Resistant Acute Graft-Versus-Host Disease treatment 1 completed NCT03297528
Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotransplant No drug interventions prevention 2 unknown_status NCT00501228
Tissue Repair in Stem Cell Transplant Recipients treatment Not Available terminated NCT00723593
Natural History and Pathophysiology of Gastrointestinal Graft-versus-Host Disease No drug interventions Not Available Not Available withdrawn NCT00004878
Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia supportive_care 2 withdrawn NCT00189488
Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation treatment 2 completed NCT02799888
Maraviroc-Based GVHD Prophylaxis in HLA-Unrelated and HLA-Mismatched Related Transplantation prevention 2 unknown_status NCT03124056
Clinical and Biomarker Study of the Efficacy of Extracorporeal Photopheresis in Graft-versus-host Disease No drug interventions Not Available Not Available completed NCT01616056
Bandage Lenses in Treating Patients With Ocular Graft-Versus-Host Disease No drug interventions supportive_care 2 completed NCT05808985
Intestinal Microbiome-based Research for the Prevention of Acute GVHD prevention 2 recruiting NCT00898885
Analysis of the Clinical and Histological Correlation of Oral Graft-Versus-Host-Disease (GVHD) No drug interventions Not Available Not Available completed NCT06279585
Physical Therapy in Patients Undergoing Allo-HSCT With cGVHD No drug interventions treatment Not Available not_yet_recruiting NCT00265837
Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer No drug interventions treatment 3 completed NCT00775632
Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants treatment 2 completed NCT01116232
Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation supportive_care 2 terminated NCT00253552
G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders treatment Not Available terminated NCT02386800
CINC424A2X01B Rollover Protocol treatment 4 recruiting NCT03357159
Anti T-lymphocyte Immunoglobulin With Post Transplant Cyclophosphamide to Prevent GVHD Post Allogeneic Transplantation treatment 2 recruiting NCT03128359
High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant supportive_care 2 completed NCT00003270
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT06252870
Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation treatment 2 recruiting NCT01002742
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802) treatment 3 completed NCT00201799
Infliximab for the Prevention of Graft-versus-Host Disease Following Allogenic Hematopoietic Stem Cell Transplantation prevention 2 completed NCT00353106
Experience of Having Chronic Graft-Versus-Host Disease No drug interventions Not Available Not Available completed NCT01857336
G-CSF Moblized Peripheral Harvest for Poor Engraftment After Stem Cell Transplantation No drug interventions treatment Not Available completed NCT00141713
The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host Disease treatment 2 completed NCT03727113
Optimization of Antibiotic Treatment in Hematopoietic Stem Cell Receptors No drug interventions Not Available Not Available completed NCT02342613
Adoptive Immunotherapy With Activated Marrow Infiltrating Lymphocytes and Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Relapse of Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation No drug interventions treatment 1 completed NCT00054613
Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease treatment 2 completed NCT00675441
Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-Vs-Host Disease (GVHD) treatment 2 terminated NCT06200441
Correlation of Serum Gasdermin-D and NLRP-3 Inflammasome Levels With GVHD Biomarkers and Endothelial Damage Markers in Graft-Versus-Host Disease No drug interventions Not Available Not Available recruiting NCT01135641
Study of First Line Treatment of Chronic Graft Versus Host Disease With the Association of Ciclosporine, Corticosteroids and Rituximab (Protocol R-GVHD) treatment 2 completed NCT01385124
Cannabidiol for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation prevention 1 / 2 unknown_status NCT00031824
Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease supportive_care 3 completed NCT00096096
Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation supportive_care 2 completed NCT05856058
To Assess SHR0302 Oral Solutions and Tablets in Healthy Subjects Clinical Studies of Relative Bioavailability basic_science 1 completed NCT00529035
Ultra-Low Dose Interleukin-2 for Refractory Chronic Graft Versus Host Disease treatment 1 completed NCT00003335
Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer treatment 2 completed NCT00284986
Safety and Efficacy of Prochymal® for the Salvage of Treatment-Refractory Acute GVHD Patients treatment 2 completed NCT02588339
Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention prevention 2 completed NCT02194439
Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease No drug interventions Not Available Not Available completed NCT01911039
Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD No drug interventions treatment 1 completed NCT03771222
Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignancies treatment 2 unknown_status NCT01240525
Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers No drug interventions treatment 2 unknown_status NCT02055625
Mesenchymal Stem Cells as a Treatment for Oral Complications of Graft-versus-host Disease treatment 1 / 2 withdrawn NCT00248430
Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer treatment 1 / 2 completed NCT00603330
Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function No drug interventions treatment 2 recruiting NCT00410657
Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant supportive_care 2 completed NCT00462657
Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease No drug interventions diagnostic Not Available unknown_status NCT00053157
Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia supportive_care Not Available completed NCT04886726
PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis No drug interventions prevention 1 recruiting NCT00513474
Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant supportive_care 1 completed NCT02561520
Safety and Efficacy of Autologous PRP and PPP Eye Drops in the Treatment of Ocular GVHD treatment 1 withdrawn NCT01927120
In Vivo Treg Expansion and Graft-Versus-Host Disease Prophylaxis prevention 2 completed NCT02511782
Transdermal Patch to Monitor Inflammatory Biomarkers of GVHD No drug interventions other Not Available completed NCT02877082
Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients prevention 2 terminated NCT01428973
Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens prevention 2 active_not_recruiting NCT01795573
Ex-vivo Expanded Donor Regulatory T Cells for Prevention of Acute Graft-Versus-Host Disease No drug interventions prevention 1 completed NCT00948727
Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell Transplantation prevention 2 completed NCT05276076
A Prospective, Open Label, Dose-escalation, SAD/MAD, Multicenter, 24weeks, Phase I/IIa Clinical Trial to Evaluate the Safety, Tolerability and Pharmacodynamics of Investigational Product (VM-001) in Patients With Graft-versus-host Disease(GvHD) No drug interventions treatment 1 / 2 not_yet_recruiting NCT00053976
Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease treatment 3 completed NCT00972660
Safety and Efficacy Study of Allogenic Mesenchymal Stem Cells to Treat Extensive Chronic Graft Versus Host Disease treatment 2 unknown_status NCT00004194
Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease supportive_care 1 / 2 unknown_status NCT01941394
Mesenchymal Stem Cells Infusion for aGVHD Prophylaxis Transplantation No drug interventions prevention 2 unknown_status NCT00003894
Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant supportive_care 2 completed NCT03367962
Detection of Graft Versus Host Disease With [18F]F-AraG No drug interventions diagnostic 1 recruiting NCT00003662
Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases treatment 2 completed NCT02193880
Safety of Post-transplant Alpha-beta Depleted T-cell Infusion Following Haploidentical Stem Cell Transplant (Haplo SCT) No drug interventions treatment Not Available completed NCT00001529
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives Not Available Not Available recruiting NCT01633229
Bone Marrow Stromal Cell Infusions for Stem Cell Transplant Complications No drug interventions treatment 1 completed NCT05333029
Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD treatment 2 not_yet_recruiting NCT02526329
Donor Regulatory T Cells in Treating Patients With Visceral Acute Graft-versus-Host Disease After Stem Cell Transplant No drug interventions treatment 1 withdrawn NCT04290429
Treatment of Patients With Teduglutide (GLP-2) for GVHD and Analysis of Paneth Cells of GVHD Patients treatment 0 completed NCT01672229
Bortezomib in Patients With Chronic Graft Versus Host Disease treatment 1 completed NCT00180089
Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation prevention 3 completed NCT00824889
Exploratory Study of Natural Killer Cells in Human Skin No drug interventions Not Available Not Available completed NCT00185692
Allogeneic Transplantation From Related Haploidentical Donors treatment 2 completed NCT01174940
Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease No drug interventions treatment 0 completed NCT00054340
Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder supportive_care 1 / 2 completed NCT00755040
Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder prevention 3 completed NCT03459040
A Proof of Concept Pilot Trial of Alpha-1-Antitrypsin for Pre-Emption Of Steroid-Refractory Acute GVHD prevention 2 completed NCT01453140
In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus treatment 1 / 2 terminated NCT00740467
Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders treatment 2 unknown_status NCT05289167
High-Dose Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD) Following Allogenic Hematopoietic Stem Cell Transplantation (HSCT) Study treatment 1 / 2 recruiting NCT03263767
Post Transplant Cyclophosphamide (PTCY) as Sole Graft Versus Host Disease (GVHD) Prophylaxis for Matched Allotransplant: CYRIC treatment 2 terminated NCT02144701
Lactobacillus Rhamnosus GG in Reducing Incidence of Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant No drug interventions supportive_care Not Available completed NCT00813501
Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases No drug interventions Not Available Not Available terminated NCT03924401
Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant prevention 2 active_not_recruiting NCT01988701
Lymphocyte Profiles and Activation Status in Patients With Graft-Versus-Host Disease No drug interventions Not Available Not Available withdrawn NCT00004904
Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 1 completed NCT02195869
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease treatment 1 / 2 completed NCT00792246
Voriconazole Pharmacokinetics in Children With Gastrointestinal Graft Versus Host Disease treatment 1 completed NCT05655546
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals No drug interventions other Not Available active_not_recruiting NCT00826046
Prochymal® Expanded Access for Adults Who Have Failed Steroid Treatment for Acute Graft Versus Host Disease (GVHD) Not Available Not Available no_longer_available NCT00781781
Alemtuzumab Use (MabCampath®) in Hematopoietic Transplant of Unrelated Donor With Reduced Intensity Conditioning treatment 2 terminated NCT02080195
Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE) treatment 1 / 2 terminated NCT00929695
Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease supportive_care 3 completed NCT00423514
Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease treatment 1 / 2 completed NCT03880214
Prevalence of Chronic Oral Graft Versus Host Disease Risk Factors in Pediatric Patients No drug interventions Not Available Not Available unknown_status NCT01789255
Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies supportive_care 2 completed NCT01485055
Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease treatment 2 terminated NCT00806208
Trial for Evaluation of Safety of Escalating Dose Levels of MEDI-507 in Patients for Treatment of at Least Grade II Graft-Versus-Host Disease (GvHD) treatment 1 completed NCT05969743
Letermovir Prophylaxis for Cytomegalovirus (CMV) in Patients With Graft-versus-host Disease prevention 2 not_yet_recruiting NCT01463475
University of Wisconsin hMSC Cell Bank: Bone Marrow Donor Protocol No drug interventions Not Available Not Available completed NCT04167514
Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone (BMT CTN 1705) treatment 3 active_not_recruiting NCT02167451
Maraviroc as GVHD Prophylaxis in Transplant Recipients prevention 1 / 2 terminated NCT01324908
Biomarkers in Predicting Response in Patients With Graft-Versus-Host Disease Undergoing Extracorporeal Photophoresis No drug interventions treatment Not Available terminated NCT03680092
Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation treatment 2 active_not_recruiting NCT06590285
Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation No drug interventions supportive_care Not Available not_yet_recruiting NCT02156479
Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Allo-HSCT Recipients No drug interventions Not Available Not Available completed NCT02066051
IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD No drug interventions treatment Not Available completed NCT06469411
Effect of PMSCs and Their Secretome for the Treatment of GvHD No drug interventions treatment 3 completed NCT02490163
Comparison of Two Automated Mononuclear Collection Systems in Patients Undergoing Extracorporeal Photochemotherapy. A Cross-over Equivalence Study. (MNC_CMNC) No drug interventions Not Available 3 completed NCT05544448
In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases No drug interventions basic_science Not Available unknown_status NCT06462365
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT) No drug interventions prevention 1 recruiting NCT06000982
Comparison of Different Dose of Post-transplantation Cyclophosphamide as Graft Versus Host Disease Prophylaxis No drug interventions prevention 3 not_yet_recruiting NCT06083129
Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated Donor prevention 3 not_yet_recruiting NCT03851601
Immuno-regulatory Profiling of T Cells in GVHD Treated With Extracorporeal Photopheresis No drug interventions Not Available Not Available completed NCT01295710
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD) No drug interventions prevention 3 completed NCT06411184
Safety and Efficacy of Treg Cell in the Treatment of GVHD No drug interventions treatment 1 / 2 not_yet_recruiting NCT04015947
Allogeneic Skin Grafting No drug interventions device_feasibility Not Available withdrawn NCT02338232
Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation treatment Not Available terminated NCT03233659
Immune Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation No drug interventions Not Available Not Available completed NCT02441075
70% Ethanol for Decontamination of CVL Exposed to Calcineurine Inhibitors Version 1.0, 1/9/2014 No drug interventions treatment Not Available completed NCT03763318
A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD treatment 1 / 2 completed NCT04945096
Outcomes of Patients After Allo-HSCT With Decitabine and NAC treatment 3 not_yet_recruiting NCT06075225
MAP-guided Preemptive Therapy of aGvHD by Ruxolitinib prevention 2 not_yet_recruiting NCT05094765
Fecal Microbiota Transplant (FMT) Capsule for Improving the Efficacy of GI-aGVHD No drug interventions treatment 0 unknown_status NCT03945591
High-Dose Post-Transplant Cyclophosphamide and Bortezomib (CyBor) for the Prevention of Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) treatment 2 completed NCT02712762
Ocular Surface Disease in Chronic Graft-Versus-Host Disease (GVHD) Patients No drug interventions Not Available Not Available completed NCT06334367
Prophylaxis of Graft-versus-host Disease With Anti-CD25 Antibody in Patients Underwent HSCT No drug interventions prevention 2 not_yet_recruiting NCT03188601
α1-antitrypsin (AAT) Levels and Functions in Allogeneic Bone Marrow Transplantation and Throughout Progression Into GVHD No drug interventions Not Available Not Available completed NCT05415410
Proof-of-concept Trial of Apraglutide in GVHD treatment 2 active_not_recruiting NCT00447460
Treatment of Refractory (Acute or Chronic) Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell No drug interventions treatment 1 / 2 unknown_status